Technical Analysis for ENDV - Endonovo Therapeutics Inc

Grade Last Price % Change Price Change
grade F 0.0013 -7.14% -0.0001
ENDV closed down 7.14 percent on Thursday, December 19, 2019, on 1.99 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ENDV trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -7.14%
New 52 Week Low Weakness -7.14%
Wide Bands Range Expansion -7.14%
Lower Bollinger Band Touch Weakness -7.14%
Oversold Stochastic Weakness -7.14%
New 52 Week Low Weakness -13.33%
Wide Bands Range Expansion -13.33%
Older signals for ENDV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Endonovo Therapeutics, Inc., formerly Hanover Portfolio Acquisitions, Inc., is a biotechnology company developing a bioelectronic approach to regenerative medicine. The Company operates through two segments: intellectual property licensing and commercialization, and biomedical research and development, which includes development of its square wave form device. Its Immunotronics platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and cell death. Its Cytotronics platform is being developed to create biologically potent cell therapies. It is using this technology to create a therapy for the treatment of Graft-Versus-Host Disease (GvHD), a rare complication following allogeneic tissue transplants. Its Cytotronics platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields for tissue engineering and cell therapies.
Medicine Biotechnology Medical Specialties Branches Of Biology Stem Cells Immunology Regenerative Medicine Inflammation Tissue Engineering Transplantation Medicine Regenerative Biomedicine Allotransplantation Graft Versus Host Disease Treatment Of Graft Versus Host Disease

Is ENDV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.0409
52 Week Low 0.0011
Average Volume 6,216,684
200-Day Moving Average 0.0110
50-Day Moving Average 0.0053
20-Day Moving Average 0.0025
10-Day Moving Average 0.0019
Average True Range 0.0010
ADX 33.39
+DI 10.0000
-DI 21.5385
Chandelier Exit (Long, 3 ATRs ) 0.0027
Chandelier Exit (Short, 3 ATRs ) 0.0041
Upper Bollinger Band 0.0040
Lower Bollinger Band 0.0010
Percent B (%b) 0.1
BandWidth 120.0000
MACD Line -0.0011
MACD Signal Line -0.0011
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0024
Resistance 3 (R3) 0.0025 0.0022 0.0022
Resistance 2 (R2) 0.0022 0.0020 0.0022 0.0021
Resistance 1 (R1) 0.0018 0.0018 0.0017 0.0017 0.0021
Pivot Point 0.0015 0.0015 0.0015 0.0015 0.0015
Support 1 (S1) 0.0011 0.0013 0.0010 0.0010 0.0005
Support 2 (S2) 0.0008 0.0011 0.0008 0.0005
Support 3 (S3) 0.0004 0.0008 0.0004
Support 4 (S4) 0.0003